1. Home
  2. VKTX vs INDB Comparison

VKTX vs INDB Comparison

Compare VKTX & INDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • INDB
  • Stock Information
  • Founded
  • VKTX 2012
  • INDB 1907
  • Country
  • VKTX United States
  • INDB United States
  • Employees
  • VKTX N/A
  • INDB N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • INDB Major Banks
  • Sector
  • VKTX Health Care
  • INDB Finance
  • Exchange
  • VKTX Nasdaq
  • INDB Nasdaq
  • Market Cap
  • VKTX 2.8B
  • INDB 2.8B
  • IPO Year
  • VKTX 2015
  • INDB N/A
  • Fundamental
  • Price
  • VKTX $26.12
  • INDB $61.01
  • Analyst Decision
  • VKTX Buy
  • INDB Buy
  • Analyst Count
  • VKTX 12
  • INDB 4
  • Target Price
  • VKTX $84.00
  • INDB $69.50
  • AVG Volume (30 Days)
  • VKTX 2.8M
  • INDB 282.5K
  • Earning Date
  • VKTX 07-23-2025
  • INDB 07-17-2025
  • Dividend Yield
  • VKTX N/A
  • INDB 3.86%
  • EPS Growth
  • VKTX N/A
  • INDB N/A
  • EPS
  • VKTX N/A
  • INDB 4.44
  • Revenue
  • VKTX N/A
  • INDB $654,155,000.00
  • Revenue This Year
  • VKTX N/A
  • INDB $27.60
  • Revenue Next Year
  • VKTX N/A
  • INDB $25.32
  • P/E Ratio
  • VKTX N/A
  • INDB $13.75
  • Revenue Growth
  • VKTX N/A
  • INDB N/A
  • 52 Week Low
  • VKTX $18.92
  • INDB $45.11
  • 52 Week High
  • VKTX $81.73
  • INDB $77.23
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 45.41
  • INDB 44.96
  • Support Level
  • VKTX $26.66
  • INDB $59.78
  • Resistance Level
  • VKTX $28.33
  • INDB $63.40
  • Average True Range (ATR)
  • VKTX 1.37
  • INDB 1.72
  • MACD
  • VKTX -0.20
  • INDB -0.38
  • Stochastic Oscillator
  • VKTX 9.58
  • INDB 13.86

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About INDB Independent Bank Corp.

Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.

Share on Social Networks: